In article <1992Dec26.013818.8234 at ringer.cs.utsa.edu>
senseman at lucy.brainlab.utsa.edu (David M. Senseman) writes:
> Haloperidol is a rather "old" dopamine blocker (=antagonist).
> As I understand it, it doesn't differentiate between D1 and D2
> receptors and in certain systems atleast, it has cross reactivity
> with serotonin.
>> The reason I'm asking? We recently did some experiments in which
> Haloperidol reduced a rather interesting neuophysiological process
> (maybe you'll read about it in Science? :-) Anyway, I would
> appreciate any info on Halperidol that the wizards on
bionet.neuroscience
> care to share.
>> Thanks. (and Merry Christmas :-)
> --
> David M. Senseman, Ph.D. | A man who has never gone to school may
steal
> (senseman at lonestar.utsa.edu) | from a freight car; but if he has a
university
> Division of Life Sciences | education, he may steal the whole
railroad.
> UT San Antonio | Theodore Roosevelt
(1858-1919)
Work at the University of Saskatchewan has suggested that survival of
hypoxic neurons is compromised by Haloperidol. What was the process..?
Andrew Penn
Neurology
University of Alberta